Eledon Pharmaceuticals (ELDN) Interest & Investment Income (2016 - 2017)
Historic Interest & Investment Income for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q1 2017 value amounting to $26000.0.
- Eledon Pharmaceuticals' Interest & Investment Income fell 5185.19% to $26000.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $136000.0, marking a year-over-year decrease of 2765.96%. This contributed to the annual value of $164000.0 for FY2016, which is 574.71% down from last year.
- According to the latest figures from Q1 2017, Eledon Pharmaceuticals' Interest & Investment Income is $26000.0, which was down 5185.19% from $23000.0 recorded in Q4 2016.
- In the past 5 years, Eledon Pharmaceuticals' Interest & Investment Income ranged from a high of $55000.0 in Q4 2015 and a low of $23000.0 during Q4 2016
- Moreover, its 4-year median value for Interest & Investment Income was $40000.0 (2015), whereas its average is $40769.2.
- Over the last 5 years, Eledon Pharmaceuticals' Interest & Investment Income had its largest YoY gain of 9600.0% in 2016, and its largest YoY loss of 5818.18% in 2016.
- Eledon Pharmaceuticals' Interest & Investment Income (Quarter) stood at $53000.0 in 2014, then grew by 3.77% to $55000.0 in 2015, then crashed by 58.18% to $23000.0 in 2016, then rose by 13.04% to $26000.0 in 2017.
- Its Interest & Investment Income stands at $26000.0 for Q1 2017, versus $23000.0 for Q4 2016 and $38000.0 for Q3 2016.